Tirzepatide through telehealth (2026)
Dual GIP/GLP-1 receptor agonist. PeptideTech has not yet verified which US telehealth providers prescribe Tirzepatide or what their plans cost, so no provider or price is listed here. All telehealth providers we list →
Plan prices, and which treatments each provider offers, are not shown. None has yet been checked against a dated source on the provider’s own site, and PeptideTech does not publish placeholder data. Check current treatments, prices and eligibility with each provider.
Rannsóknarleiðin er eitthvað annað
Tirzepatide er einnig selt sem rannsóknarhylki eingöngu fyrir rannsóknarstofuvinnu. Það er ekki læknishjálp og ekki til neyslu í mönnum; þau eru ekki staðgenglar.
Tirzepatide rannsóknarverð →